UNSPSC 51122604: Lovastatin/niacin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV350. This VA Drug Class (CV350) classifies this compound as belonging to the group ANTILIPEMIC AGENTS.

UNSPSC 51122604 Lovastatin/niacin is a Commodity code that in recent state and local procurement activity covers emergency medical supply acquisitions, specifically advanced life support medications for fire rescue and emergency services. The City of Tampa's purchasing activity under this code reflects a scope broader than the code's nominal pharmaceutical name — state and local buyers are soliciting multiple formulation vials and injections for field emergency use, with strict expiration and delivery requirements tied to operational readiness. Issuing bodies include municipal fire and rescue departments procuring through city purchasing offices. The solicitations show a focus on goods procurement with warranty and replacement obligations, FOB delivery to the buyer's location, and firm pricing that includes transportation costs.

The City of Tampa represents the primary recent activity for this code, posting IFB 26P00188 on April 24, 2026, with a response deadline of April 8, 2026 (note: the posted date postdates the due date in the source record, indicating potential data lag or amendment). The solicitation, valued at $40,000, sought four line items of injectable medications for Tampa Fire Rescue operations in Hillsborough County, Florida, with a one-year contract term and renewal options. The City applied a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount (up to $10,000) and required vendors to supply Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation meeting WCAG 2.2 Level AA and Section 508 standards. No additional state or local opportunities appear in the recent record for this code.